Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nagaraju

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|January 1, 1981
Viloxazine and the depressed schizophrenic--methodological issuesA A Kurland, A Nagaraju
Journal of Clinical Pharmacology|October 1, 1982
Flutroline in the treatment of the schizophrenic patientA A Kurland, A Nagaraju, T E Hanlon
Journal of Clinical Pharmacology|October 1, 1980
The dopamine radioreceptor assay--a clinical applicationA A Kurland, A Nagaraju, T E Hanlon
Journal of Clinical Pharmacology|November 1, 1983
The prolactin response to flutroline hydrochloride in schizophrenic patientsA A Kurland, A Nagaraju, T E Hanlon, et al.
Journal of Clinical Pharmacology|January 1, 1981
A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patientsA A Kurland, A Nagaraju, T E Hanlon, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|June 26, 2023
COVID-19 Associated MucormycosisSana Tazeem, A Nagaraju, Hazeera Begum, et al.
Journal of Medicinal Chemistry|October 18, 2002
Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivativesG R Desiraju, B Gopalakrishnan, R K R Jetti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|January 1, 1981
Viloxazine and the depressed schizophrenic--methodological issuesA A Kurland, A Nagaraju
Journal of Clinical Pharmacology|October 1, 1982
Flutroline in the treatment of the schizophrenic patientA A Kurland, A Nagaraju, T E Hanlon
Journal of Clinical Pharmacology|October 1, 1980
The dopamine radioreceptor assay--a clinical applicationA A Kurland, A Nagaraju, T E Hanlon
Journal of Clinical Pharmacology|November 1, 1983
The prolactin response to flutroline hydrochloride in schizophrenic patientsA A Kurland, A Nagaraju, T E Hanlon, et al.
Journal of Clinical Pharmacology|January 1, 1981
A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patientsA A Kurland, A Nagaraju, T E Hanlon, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|June 26, 2023
COVID-19 Associated MucormycosisSana Tazeem, A Nagaraju, Hazeera Begum, et al.
Journal of Medicinal Chemistry|October 18, 2002
Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivativesG R Desiraju, B Gopalakrishnan, R K R Jetti, et al.
Pageof 1